Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Harvard Business Review|February 24, 2001
Integration managers: special leaders for special timesR N Ashkenas, S C FrancisHarvard Business Review|December 8, 1997
Making the deal real: how GE Capital integrates acquisitionsR N Ashkenas, L J DeMonaco, S C FrancisForensic Science International|May 2, 2015
An investigation into the enhancement of sea-spray exposed fingerprints on glassS L Goldstone, S C Francis, S J GardnerAmerican Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 14, 2002
Gene therapy in cardiovascular disease. Current statusS C Francis, M J Katovich, C H Gelband, et al.Acta Tropica|May 17, 2020
Beyond the barrier: Female Genital Schistosomiasis as a potential risk factor for HIV-1 acquisitionA S Sturt, E L Webb, S C Francis, et al.Journal of Hypertension|April 25, 2000
Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertensionM K Raizada, S C Francis, H Wang, et al.Journal of Hypertension|September 21, 2001
Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertensionM J Katovich, P Y Reaves, S C Francis, et al.Hypertension (Dallas, Tex. : 1979)|March 7, 2001
The future of hypertension therapy: sense, antisense, or nonsense?A S Pachori, M J Huentelman, S C Francis, et al.Physiological Genomics|January 5, 2002
Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?S C Francis, M K Raizada, A A Mangi, et al.Pageof 1